Nano-X Imaging (NNOX) Current Deferred Revenue (2021 - 2025)
Historic Current Deferred Revenue for Nano-X Imaging (NNOX) over the last 5 years, with Q3 2025 value amounting to $273000.0.
- Nano-X Imaging's Current Deferred Revenue fell 808.08% to $273000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $273000.0, marking a year-over-year decrease of 808.08%. This contributed to the annual value of $140000.0 for FY2024, which is 47837.84% up from last year.
- Latest data reveals that Nano-X Imaging reported Current Deferred Revenue of $273000.0 as of Q3 2025, which was down 808.08% from $84000.0 recorded in Q2 2025.
- In the past 5 years, Nano-X Imaging's Current Deferred Revenue ranged from a high of $662000.0 in Q4 2021 and a low of -$107000.0 during Q1 2023
- Its 5-year average for Current Deferred Revenue is $186625.0, with a median of $98000.0 in 2025.
- In the last 5 years, Nano-X Imaging's Current Deferred Revenue plummeted by 34583.33% in 2023 and then surged by 220000.0% in 2025.
- Nano-X Imaging's Current Deferred Revenue (Quarter) stood at $662000.0 in 2021, then dropped by 12.39% to $580000.0 in 2022, then decreased by 6.38% to $543000.0 in 2023, then crashed by 74.22% to $140000.0 in 2024, then surged by 95.0% to $273000.0 in 2025.
- Its last three reported values are $273000.0 in Q3 2025, $84000.0 for Q2 2025, and $112000.0 during Q1 2025.